Viewing Study NCT01762033


Ignite Creation Date: 2025-12-25 @ 2:46 AM
Ignite Modification Date: 2026-04-15 @ 4:58 PM
Study NCT ID: NCT01762033
Status: TERMINATED
Last Update Posted: 2016-01-20
First Post: 2012-12-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 2 Study of ASONEP™ to Treat Unresectable and Refractory Renal Cell Carcinoma
Sponsor: Lpath, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module